Afya $AFYA

Consumer Discretionary · NASDAQ

Brazil
$9.53
-0.19 (-1.95%)
As of Nov 20, 2026, 4:05 PM EST · cached
Price history
Loading chart…
Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Oct 7, 2026, the first target we tracked for AFYA.

Afya (AFYA) is trading down at $9.53 (-1.95%) on NASDAQ, as of the latest quote. It operates in the Consumer Discretionary sector.

IPO: July 19, 2019 · $19.00 offering · NASDAQ

Analyst price targets on AFYA

One firm's current price target on Afya: $19 — 99% above the current $9.53. Each is tracked to its date and scored the same way a member's call is.

1 target, newest first. Open a row for its source and scoring.

DateOct 7, 2026 FirmJPMorgan RatingOverweight · lowers Targetat $13.9 · $19 +37% Horizonby Oct 2027 StatusOpen

Entry price $13.9, the close nearest Oct 7, 2026, when the target was reported; the target is +37% from it.

Horizon No horizon stated, so it is tracked over the 12-month default, to Oct 2027.

Scoring Open: judged on the close on Oct 7, 2027.

Source JPMorgan upgrades Afya stock rating on merger synergies Investing.com · Oct 7, 2026 · opens the publisher's site
JPMorgan upgraded Afya Ltd. (NASDAQ:AFYA) to Overweight from Neutral on Wednesday, while lowering its price target to $19.00 from $21.00.

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

Afya revenue & net income history (FY2017–FY2025)

RevenueNet incomeNet margin (right axis, %)
R$3.70BR$1.85BR$0FY2017 revenue: R$216.0MFY2017 net income: R$45.4M · Net margin 21.0%'17FY2018 revenue: R$333.9MFY2018 net income: R$86.4M · Net margin 25.9%'18FY2019 revenue: R$750.6MFY2019 net income: R$153.9M · Net margin 20.5%'19FY2020 revenue: R$1.20BFY2020 net income: R$292.1M · Net margin 24.3%'20FY2021 revenue: R$1.72BFY2021 net income: R$223.3M · Net margin 13.0%'21FY2022 revenue: R$2.33BFY2022 net income: R$373.6M · Net margin 16.0%'22FY2023 revenue: R$2.88BFY2023 net income: R$386.3M · Net margin 13.4%'23FY2024 revenue: R$3.30BFY2024 net income: R$631.5M · Net margin 19.1%'24FY2025 revenue: R$3.70BFY2025 net income: R$752.5M · Net margin 20.4%'250%10%20%30%FY2017 net margin: 21.0%FY2018 net margin: 25.9%FY2019 net margin: 20.5%FY2020 net margin: 24.3%FY2021 net margin: 13.0%FY2022 net margin: 16.0%FY2023 net margin: 13.4%FY2024 net margin: 19.1%FY2025 net margin: 20.4%
Afya annual financial statements
FY2017Dec 2017FY2018Dec 2018FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
RevenueR$216.0MR$333.9MR$750.6MR$1.20BR$1.72BR$2.33BR$2.88BR$3.30BR$3.70B
Growth (year over year)—+54.6%+124.8%+60.0%+43.1%+35.5%+23.5%+14.9%+11.9%
Gross profitR$91.9MR$165.9MR$441.8MR$766.5MR$1.07BR$1.47BR$1.77BR$2.09BR$2.38B
Gross margin42.6%49.7%58.9%63.8%62.1%63.1%61.4%63.2%64.5%
Operating incomeR$49.3MR$96.4MR$205.3MR$363.3MR$440.9MR$664.1MR$767.1MR$1.01BR$1.21B
Operating margin22.8%28.9%27.3%30.2%25.6%28.5%26.7%30.6%32.8%
Net incomeR$45.4MR$86.4MR$153.9MR$292.1MR$223.3MR$373.6MR$386.3MR$631.5MR$752.5M
Net margin21.0%25.9%20.5%24.3%13.0%16.0%13.4%19.1%20.4%
EPS (diluted)R$1.41R$1.81R$2.02R$3.12R$2.37R$4.12R$4.27R$6.93R$8.24
Balance sheet
Cash and equivalentsR$25.5MR$62.3MR$943.2MR$1.05BR$748.6MR$1.09BR$553.0MR$911.0MR$1.13B
Total assets—R$918.4MR$2.91BR$4.79BR$6.45BR$7.20BR$7.58BR$8.83BR$9.36B
Total liabilities—R$328.1MR$798.7MR$1.96BR$3.45BR$3.95BR$3.94BR$4.52BR$4.47B
Shareholders' equityR$46.8MR$502.0MR$2.07BR$2.78BR$2.95BR$3.20BR$3.60BR$4.27BR$4.85B
Cash flow
Operating cash flowR$39.9MR$80.3MR$299.2MR$371.5MR$630.9MR$843.9MR$1.04BR$1.43BR$1.53B
Capital expenditureR$16.8MR$18.6MR$57.0MR$89.8MR$125.9MR$168.1MR$118.4MR$136.9MR$166.0M
Free cash flowR$23.1MR$61.7MR$242.3MR$281.7MR$505.0MR$675.8MR$925.2MR$1.30BR$1.37B
Dividends paidR$2.51MR$5.84MR$51.8MR$13.0MR$18.6MR$19.7MR$18.8MR$18.3MR$146.8M

From Afya's 20-F filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. Amounts are in Brazilian Real (BRL), as reported, not converted to dollars. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →

Afya in the news

Nov 14, 2026 The Globe and Mail Analysts Are Bullish on These Consumer Goods Stocks: Coca-Cola (KO), Afya (AFYA)
Nov 13, 2026 Investing.com Afya earnings beat by R$0.11, revenue fell short of estimates
Nov 12, 2026 Investing.com Afya 9M26 slides: market leader shows solid growth, investment phase
Nov 5, 2026 Investing.com Morgan Stanley upgrades Afya stock rating on valuation despite merger concerns
Oct 7, 2026 Investing.com JPMorgan upgrades Afya stock rating on merger synergies Target

About Afya

Headquarters
Belo Horizonte, Minas Gerais, Brazil From SEC filings, Oct 2026

More Consumer Discretionary stocks

Browse all companies →